Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma

James Lally(Esperion Therapeutics (United States)), Bryan C. Fuchs(Massachusetts General Hospital), Theodoros Tsakiridis(Juravinski Cancer Centre), Derek J. Erstad(Harvard University), Ricard Masia(BioSurfaces (United States)), Sarani Ghoshal(Harvard University), Alexander Anagnostopoulos(McMaster University), Vivian Leong(McMaster University), Sathesh Bhat(Schrodinger (United States)), Naoto Fujiwara(The University of Texas Southwestern Medical Center), Adrian S. Ray(Maine Farmland Trust), Jamie Bates(Gilead Sciences (United States)), Kenneth K. Tanabe(Harvard University), Omeed Moaven(Louisiana State University), H. James Harwood(North Carolina State University), William Westlin(Brigham and Women's Hospital), Lindsay A. Broadfield(VIB-KU Leuven Center for Cancer Biology), Vanessa P. Houde(McMaster University), Hailing Sun(Gilead Sciences (United States)), Paola Muti(Department of Public Health), Gregory R. Steinberg(McMaster University Medical Centre), Rebecca J. Ford(McMaster University), Asish K. Saha(Boston University), Danielle K. DePeralta(Roswell Park Comprehensive Cancer Center), Jeremy R. Greenwood(Schrodinger (United States)), Geraldine Harriman, Jennifer L. Rocnik(Novartis (United States)), Ting Wang(Jilin University), Lan Wei(University College Dublin), Alice Wang(Massachusetts Institute of Technology), Henry Liu(Penn State Milton S. Hershey Medical Center), Robert A. Foster(University of Guelph), Yujin Hoshida(Broad Institute), Wenyan Miao(Millennium Engineering and Integration (United States)), Rosana Kapeller(Unknown)
Cell Metabolism
September 20, 2018
Cited by 420


Related Papers